Tolperisone
From Wikipedia, the free encyclopedia
|
Tolperisone
|
|
| Systematic (IUPAC) name | |
| 2-methyl-1-(4-methylphenyl)-3-(1-piperidyl)propan-1-one | |
| Identifiers | |
| CAS number | |
| ATC code | M03 |
| PubChem | |
| Chemical data | |
| Formula | C16H23NO |
| Mol. mass | 245.36 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Tolperisone, a piperidine derivative, is a centrally acting muscle relaxant. Brand names include Mydocalm and Mydeton.
[edit] External links
- Hofer D, Lohberger B, Steinecker B, Schmidt K, Quasthoff S, Schreibmayer W (2006). "A comparative study of the action of tolperisone on seven different voltage dependent sodium channel isoforms.". Eur J Pharmacol 538 (1-3): 5–14. doi:. PMID 16650844.
- Kocsis P, Farkas S, Fodor L, Bielik N, Thán M, Kolok S, Gere A, Csejtei M, Tarnawa I (2005). "Tolperisone-type drugs inhibit spinal reflexes via blockade of voltage-gated sodium and calcium channels.". J Pharmacol Exp Ther 315 (3): 1237–46. doi:. PMID 16126840.
- Ribi C, Vermeulen C, Hauser C (2003). "Anaphylactic reactions to tolperisone (Mydocalm).". Swiss Med Wkly 133 (25-26): 369–71. PMID 12947534.
|
|||||||||||||||||||||||||||||||||

